Hepatic Diseases in Brazil: Prevalence and Prevention

Dr. Alberto Carneiro and Dr. Alberto discuss the increasing prevalence of liver diseases in Brazil, particularly hepatitis and steatosis, underscoring their treatments and the importance of early diagnosis. Hepatitis is a public health issue due to its transmissible nature, with viral types A, B, and C transmitted differently; type A primarily via contaminated water, while types B and C spread through blood. Brazil stands out for its liver transplant achievements, becoming a world leader in surgeries performed under the Unified Health System (SUS). Although obesity and sedentary lifestyles are risk factors, vaccination and early detection are critical for preventing liver diseases. Transplantation is a viable option for patients with terminal liver conditions, with an efficient network in Brazil reducing waiting times for donations. Additionally, hepatic steatosis, commonly known as fatty liver, is increasingly problematic, particularly among youth, with treatment options available in public health systems. Early detection of diseases and improved dietary habits are vital, with SUS maintaining a strong role in prevention and treatment, thereby reinforcing the country's healthcare infrastructure.